Programmed death-ligand 1 (PD-L1) is highly expressed in aggressive papillary and anaplastic thyroid carcinomas, functioning as a key immune checkpoint whose upregulation enables tumour cells to escape cytotoxic surveillance and accelerate disease progression. This evidence concerns the gene CD274 and neoplasm.